ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

NIH Budget Cut At $142 Million, NCI Could Get Small Increase Over 1981 Total; Schweiker Backs NIH Funds

February 27, 1981